PCM
MRNA icon

Polymer Capital Management’s Moderna MRNA Stock Holding History

Polymer Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Sell
7,002
-6,966
-50% -$360K 0.06% 396
2026
Q1 		$710K Buy
+13,968
New +$652K 0.07% 293
2025
Q4 		– Sell
-13,311
Closed -$344K – 921
2025
Q3 		$344K Buy
+13,311
New +$371K 0.04% 570

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Polymer Capital Management's MRNA Position: Q2 2026 in Review

Polymer Capital Management reduced its Moderna (MRNA) stake by 50% in Q2 2026, selling an estimated $360K and leaving 7,002 shares worth $490K. The position accounts for 0.06% of the portfolio, ranked #396.

Polymer Capital Management first reported a position in MRNA in Q3 2025 and has held it in 3 quarters since. The position peaked at $710K in Q1 2026. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Polymer Capital Management held 7,002 shares of Moderna worth $490K as of Q2 2026.
  • Polymer Capital Management sold 6,966 Moderna shares in Q2 2026, an estimated $360K.
  • Moderna made up 0.06% of Polymer Capital Management's portfolio in Q2 2026, its #396 holding.
  • Polymer Capital Management first reported a position in Moderna in Q3 2025 and has held it in 3 quarters since.
  • Polymer Capital Management's Moderna position peaked at $710K in Q1 2026.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.